Investor Relations

Invest in West Africa's pharmaceutical future

The Series A round is now open.

95%
imports today
$8.5B
market size
300M
units/year
$20.3M
LOI pipeline
Roadmap to production
2024 โ€” Foundation

Company founded; FONSIS backing secured.

2025 โ€” Series A

Capital raise; regulatory dossier submitted.

2026 โ€” Build

Construction of the Dakar facility.

2027 โ€” Production

First commercial production.

Request the investor deck

Full deck and financial model available to qualified investors under NDA.

Contact Investor Relations